Skip to content

The feasibility of a brain tumor website

The feasibility of a brain tumor website among patients with high-grade gliomas and the caregivers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN22038059
Enrollment
60
Registered
2013-05-08
Start date
2012-05-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with primary malignant brain tumor of the type high-grade glioma (WHO grade III/VI). Cancer Malignant neoplasm of brain

Interventions

Phase I: Participants will be interviewed individually five times over a 12 months period starting at baseline (Test 1: time of diagnosis). Test 2 takes place 5-6 weeks post-operatively, which is appr

Sponsors

Copenhagen University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. A diagnosis of HGG (WHO grade III/IV) in persons > 18 years of age, either sex that are capable of speaking and understanding Danish and that have a Karnofsky performance score (KSP) > 60 at baseline 2. Caregivers are eligible if they are named by the patient as the most involved caregiver, and will provide written informed consent 3. Access to the Internet

Exclusion criteria

Exclusion criteria: 1. Karnofsky performance score < 60 at baseline 2. Other types of primary brain tumors than HGG 3. No Internet access 4. No standard treatment

Design outcomes

Secondary

MeasureTime frame
1. To systematically assess the patients´ needs for rehabilitation along the course of the disease 2. To describe how symptoms are experienced and managed 3. To elucidate the resources of the caregivers and any independent needs related to the patient's disease 4. To gain an understanding of what a survivorship program should comprise 5. To develop a targeted intervention for rehabilitation of patients with HGG and their caregivers 6. Assess safety of the BTW

Primary

MeasureTime frame
The primary aim of phase I is to explore the life situation, needs and experiences across the disease and treatment continuum in patients diagnosed with HGG and their caregivers. The aim of phase II is to study the feasibility of a survivorship program designed from the perspectives in the existing literature and the experiences of the patients and their caregivers obtained in the present study. Data includes: 1. The number of users 2. Logged-in members 3. Postcodes from which the BTW was accessed 4. Types of devices used to access the BTW 5. Number of first time versus returning users 6. Type of activity (number of sessions, most visited pages, use of telephone support) Individual telephone interviews were conducted with the participants by the principal investigator and clinical specialist after three months. Using a semi-structured interview guide, participants were asked to share their experiences and evaluation of the BTW.

Countries

Denmark

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 17, 2026